DK1427297T3 - Appetitnedsættende procyanidin-holdigt præparat til pattedyr - Google Patents

Appetitnedsættende procyanidin-holdigt præparat til pattedyr

Info

Publication number
DK1427297T3
DK1427297T3 DK02763085T DK02763085T DK1427297T3 DK 1427297 T3 DK1427297 T3 DK 1427297T3 DK 02763085 T DK02763085 T DK 02763085T DK 02763085 T DK02763085 T DK 02763085T DK 1427297 T3 DK1427297 T3 DK 1427297T3
Authority
DK
Denmark
Prior art keywords
procyanidin
appetite
preparation
reducing
containing mammalian
Prior art date
Application number
DK02763085T
Other languages
English (en)
Inventor
Arie Gijsbert Nieuwenhuizen
Laere Katrien Maria Jozefa Van
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1427297T3 publication Critical patent/DK1427297T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK02763085T 2001-09-20 2002-09-20 Appetitnedsættende procyanidin-holdigt præparat til pattedyr DK1427297T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/956,463 US6638542B2 (en) 2001-09-20 2001-09-20 Reducing appetite in mammals by administering procyanidin and hydroxycitric acid

Publications (1)

Publication Number Publication Date
DK1427297T3 true DK1427297T3 (da) 2006-04-03

Family

ID=25498267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02763085T DK1427297T3 (da) 2001-09-20 2002-09-20 Appetitnedsættende procyanidin-holdigt præparat til pattedyr

Country Status (10)

Country Link
US (1) US6638542B2 (da)
EP (1) EP1427297B1 (da)
AT (1) ATE311765T1 (da)
CA (1) CA2460824A1 (da)
DE (1) DE60207877T2 (da)
DK (1) DK1427297T3 (da)
ES (1) ES2254721T3 (da)
GB (1) GB2395434A (da)
MX (1) MXPA04002623A (da)
WO (1) WO2003024245A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001527022A (ja) 1997-07-14 2001-12-25 ラジュ、ジー・ガンガ ヒドロキシクエン酸組成物、前記組成物から製造された補助医薬品及び補助食品及び食品並びに体重を低減させることにおけるそれらの使用方法
US20040157929A1 (en) * 2002-04-01 2004-08-12 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating(-)hydroxycitric acid, and related compositions thereof
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US20030119913A1 (en) * 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
EP1480636B1 (en) * 2002-03-01 2007-04-18 Novagali Pharma SA Self emulsifying drug delivery systems for taxoids
WO2004085462A2 (en) * 2003-03-21 2004-10-07 Interhealth Nutraceuticals Incorporated Method and composition for decreasing ghrelin levels
CN102309573B (zh) * 2003-09-12 2013-11-20 捷通国际有限公司 细胞因子调节剂及相关用法
US7758902B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
US8551554B2 (en) * 2003-12-29 2013-10-08 Cornell Research Foundation, Inc. Apple peel powder, methods of making, and uses thereof
US20050215644A1 (en) * 2004-03-19 2005-09-29 Interhealth Nutraceuticals, Inc. Methods for increasing neurotransmitter levels using hydroxycitric acid
US20080089962A1 (en) * 2004-09-24 2008-04-17 Multi Formulations Ltd. Nutritional composition for facilitating muscle pumps
US20050256192A1 (en) * 2004-04-30 2005-11-17 Gardiner Paul T Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
JP4880591B2 (ja) 2004-06-04 2012-02-22 テバ ファーマシューティカル インダストリーズ リミティド イルベサルタンを含む医薬組成物
EP1827139A2 (en) * 2004-12-14 2007-09-05 Lean Balance Formulations Ltd. Supplement dietary composition for promoting weight loss
WO2006128259A1 (en) * 2005-06-03 2006-12-07 Horizon Science Pty Ltd Substances having body mass redistribution properties
US7579027B2 (en) * 2005-09-20 2009-08-25 Grethe Stoa Birketvedt Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves
DE102006038793A1 (de) * 2006-08-18 2008-02-21 Jp Healthcare Gmbh Nahrungsergänzungsmittel
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
DE102009005201A1 (de) * 2009-01-20 2010-07-22 Universität Rostock Verwendung von Polyphenol-haltigen Pflanzenextrakten zur Behandlung von Adipositas und Diabetes mellitus Typ 2
CN103829254A (zh) * 2013-12-20 2014-06-04 浙江大学 一种原花青素在制备减肥食品或药品中的应用
ES2570433B1 (es) * 2014-10-17 2016-11-21 Universitat Rovira I Virgili Utilización de proantocianidinas para la supresión del apetito o inducción de la saciedad
CN105707873A (zh) * 2016-04-06 2016-06-29 黄汉 一种原花青素的保健品组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989822A (en) * 1974-02-14 1976-11-02 Purdue Research Foundation Weight control compound
WO1997023210A1 (fr) * 1995-12-26 1997-07-03 Suntory Limited Agent anti-obesite dont le principe actif est la procyanidine
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US5911992A (en) * 1997-06-12 1999-06-15 A. Glenn Braswell Method for controlling weight with hypericum perforatum and garcinia cambogia
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols

Also Published As

Publication number Publication date
ES2254721T3 (es) 2006-06-16
US20030064937A1 (en) 2003-04-03
DE60207877T2 (de) 2006-07-20
ATE311765T1 (de) 2005-12-15
EP1427297B1 (en) 2005-12-07
GB2395434A (en) 2004-05-26
CA2460824A1 (en) 2003-03-27
EP1427297A1 (en) 2004-06-16
DE60207877D1 (de) 2006-01-12
US6638542B2 (en) 2003-10-28
GB0406384D0 (en) 2004-04-21
MXPA04002623A (es) 2004-07-08
WO2003024245A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
DK1427297T3 (da) Appetitnedsættende procyanidin-holdigt præparat til pattedyr
HUP0003386A2 (hu) CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására
MY120279A (en) Use of a celecoxib composition for fast pain relief
MY126555A (en) Oral pharmaceutical extended release dosage form
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
DK0996429T3 (da) Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
GB9902453D0 (en) Chemical compounds
NZ514574A (en) Novel method of treatment
MXPA01012882A (es) Composiciones y metodos que comprenden gluconato de morfina.
MY140938A (en) Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
DE69015736D1 (de) 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate.
DE602004019777D1 (de) STABILE PHARMAZEUTISCHE ZUBEREITUNGEN MIT 2-AZA-BICYCLOi3.3.0 -OCTAN-3-CARBOXYLSÄURE-DERIVATEN
GB0003025D0 (en) Novel compounds
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
WO2003022280A3 (en) 3-glyoxlylamideindoles for treating cancer
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
CA2361081A1 (en) Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
TR199901631T2 (xx) Klavülanik asitin esterleri ve tuzlarının hazırlanması için işlem.
HU0102118D0 (en) Process for chloromethylation
DE60111196D1 (de) Molsidominhaltige oral anzuwendende verabreichungsform mit verzögerter wirkstoffabgabe
DE60121142D1 (de) Zusammensetzung die paracetamol und niflumic säure enthält